Medical Council of India cannot prohibit pharma companies

Recent Posts

• Delay in Filing Form 10B is Procedural – Substantive Exemption under Section 11 Cannot Be Denied on Technical Grounds
• Survey Statement u/s 133A Has No Evidentiary Value – Additions Quashed
• Income has escaped assessment is a pre-condition for re-opening the assessment and not a borrowed satisfaction from outside source
• Section 119(2)(b) Condonation of Delay: Who Has the Power to Grant Relief for Refunds and Section 80P Claims?
• Loans repaid in the subsequent assessment years – No addition u/s 68 can be made: ITAT Gauhati
• Section 269SS Not Attracted to One-Time Cash Sale Consideration: ITAT Chandigarh Clarifies the Law
• Tax Refund Delays: Not Always CPC’s Fault, Not Always Yours Either
• ITC Denial to Bona Fide Purchaser Solely Due to Retrospective Cancellation of Seller’s GST Registration – Supreme Court Issues Notice
• All orders in ‘E-Proceedings’ must be signed digitally: Manually signed Assessment Order held invalid by ITAT
• Rs. 5.37 Crore Refund Stuck for 8 Years: HC Reprimands Tax Dept. for Its Callous and Negligent Attitude